Your browser does not support JavaScript!

FranceBiotechnologies

FranceBiotechnologies est une plateforme pour découvrir les actualités, entreprises, produits et savoir-faire techniques de la biotechnologies. Partagez et échangez entre spécialistes.

Rejoignez la communauté
Une actualité de Labiotech.eu a été ajouté(e)
Hier à 16:57
New biotech company aims to bridge gap between stem cell research and athletic injuries
Andrews Medicine of Pensacola, Florida, and Celltex Therapeutics Corporation of Houston, Texas, are to form a new biotechnology company to bridge the divide between stem cell research and the current...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Hier à 12:12
FDA fast tracks Immutep non-small cell lung cancer candidate
Immutep Limited says the United States Food and Drug Administration (FDA) has granted fast track designation to eftilagimod alpha (efti or IMP321) in combination with pembrolizumab for the treatment...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Hier à 08:34
Big Idea Ventures announces cohort of 17 start-ups
Big Idea Ventures has revealed its latest accelerator cohort. Seventeen early-stage startups were selected for pre-seed investment as part of Big Idea Ventures’ bi-annual new protein accelerator...
www.labiotech.eu
Une question a été posée - Il y a 2 jours
Image Pompe LPA 2
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 3 jours
FDA clears Kira Pharmaceuticals’ phase 2 trial for SLE-TMA treatment 
Kira Pharmaceuticals says the US Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for KP104, a first-in-class bifunctional biologic that selectively and...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 3 jours
Estrella and TradeUP merge to become publicly traded company
Estrella Biopharma, Inc. and TradeUP Acquisition Corp. have entered into a definitive business combination agreement that will result in Estrella becoming a publicly listed company. Upon closing of...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 3 jours
Oncopeptides starts European commercialization of myeloma drug in Germany
Swedish biotech company Oncopeptides AB has initiated the commercial launch of Pepaxti (melphalan flufenamide) in Germany. It marks the first market in Europe where the drug is being launched. On...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 4 jours
Kling Biotherapeutics doses first patient in advanced solid tumor trial
Kling Biotherapeutics BV has dosed the first patient with KBA1412 in its phase 1b trial to evaluate the safety, tolerability, PK/PD, and potential efficacy of KBA1412 in adult patients with advanced...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 4 jours
Beyond Biotech podcast 16: Adocia, Omnio, Phenomix Sciences, Tridek-One
This week, we have four guests: Olivier Soula, deputy-CEO and director of R&D at Adocia; Ulrika Norin, CEO of Omnio; Mark Bagnall, CEO of Phenomix Sciences; and Laurence de Schoulepnikoff, CEO of...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 4 jours
Treatment for hot flushes and night sweats accepted for regulatory review by EMA
A treatment for moderate to severe vasomotor symptoms (VMS) has been accepted by the European Medicines Agency (EMA) for regulatory review. Astellas Pharma Inc., submitted a marketing authorization...
www.labiotech.eu
Charger plus d'actualités